A new target in non-small cell lung cancer: ROS1 fusion gene.
10.3760/cma.j.issn.0253-3766.2013.01.001
- Author:
Wei-jing CAI
;
Bo SU
- Publication Type:Journal Article
- MeSH:
Antigens, Differentiation, B-Lymphocyte;
genetics;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
genetics;
metabolism;
Gene Fusion;
Gene Rearrangement;
Histocompatibility Antigens Class II;
genetics;
Humans;
Immunohistochemistry;
In Situ Hybridization, Fluorescence;
Lung Neoplasms;
drug therapy;
genetics;
metabolism;
Protein Kinase Inhibitors;
therapeutic use;
Protein-Tyrosine Kinases;
antagonists & inhibitors;
genetics;
metabolism;
Proto-Oncogene Proteins;
antagonists & inhibitors;
genetics;
metabolism;
Pyrazoles;
therapeutic use;
Pyridines;
therapeutic use;
Reverse Transcriptase Polymerase Chain Reaction;
Signal Transduction;
Sodium-Phosphate Cotransporter Proteins, Type IIb;
genetics
- From:
Chinese Journal of Oncology
2013;35(1):1-4
- CountryChina
- Language:Chinese
